BCM
EW icon

Blume Capital Management’s Edwards Lifesciences EW Stock Holding History

Blume Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,440
Closed -$18K – 216
2014
Q1 		$18K Hold
1,440
– – 0.01% 156
2013
Q4 		$16K Buy
+1,440
New +$16.2K 0.01% 186

Other funds holding EW

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Blume Capital Management's EW Position: Q2 2014 in Review

Blume Capital Management sold out of Edwards Lifesciences (EW) in Q2 2014, closing a stake of 1,440 shares — an estimated $18K sold.

Blume Capital Management first reported a position in EW in Q4 2013 and held it in 2 quarters. The position peaked at $18K in Q1 2014. 429 funds tracked by Wall St. Rank hold EW as of Q2 2014.

  • Blume Capital Management reported no remaining Edwards Lifesciences position as of Q2 2014 after selling out during the quarter.
  • Blume Capital Management sold 1,440 Edwards Lifesciences shares in Q2 2014, an estimated $18K.
  • Blume Capital Management first reported a position in Edwards Lifesciences in Q4 2013 and held it in 2 quarters.
  • Blume Capital Management's Edwards Lifesciences position peaked at $18K in Q1 2014.
  • 429 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2014.

Based on Blume Capital Management's 13F filing for Q2 2014, filed 29 Jul 2014.